GLP-1 receptor agonists such as semaglutide and liraglutide are prescribed for diabetes and, under specific NICE criteria, weight management through specialist services
The success of Semaglutide GLP-1 extends beyond physical health benefits to include psychological improvements
Goswami R, Marwaha RK, Gupta N, et al
Robard Corporation, a leading provider of obesity treatment programs and scientifically-designed nutrition products for the medical community since 1976, has announced the launch of Biocare , a direct-to-consumer dietary beverage for people using glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications for weight loss, such as Wegovy or Ozempic (semaglutide), as well as Mounjaro or Zepbound (tirzepatide)
All products are supplied strictly for laboratory and research use only (RUO)